FIELD: medicine.
SUBSTANCE: compounds and methods for myocardial perfusion visualization are described, comprising administration of a compound associated with visualization moiety, wherein the said compound binds to the mitochondrial complex I (MC-I), and patient scanning by diagnostic imaging. The invention also relates to kits containing the said compound or precursor compounds, associated or not with the visualization moiety.
EFFECT: visualization compounds make an important diagnostic marker available for myocardial perfusion visualization.
7 cl, 1 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF | 2011 |
|
RU2631500C2 |
DEUTERATED HETEROCYCLIC COMPOUNDS AND USE THEREOF AS IMAGING MEANS | 2015 |
|
RU2696492C2 |
DEUTERATED HETEROCYCLIC COMPOUNDS AND THEIR USE AS IMAGING TOOLS | 2015 |
|
RU2791900C1 |
COMPOSITIONS, METHODS AND SYSTEMS FOR SYNTHESIS AND USE OF IMAGING AGENTS | 2011 |
|
RU2710736C2 |
TRICYCLIC INDOLE DERIVATIVES AS PBR LIGANDS | 2010 |
|
RU2525196C2 |
METHOD OF MYOCARDIAL BLOOD PERFUSION IMAGING | 2012 |
|
RU2648358C2 |
ISATIN DERIVATIVES APPLICABLE AS IMAGING IN VIVO AGENTS | 2009 |
|
RU2535975C2 |
INDOLE DERIVATIVES SUITABLE FOR VISUALISATION OF NEUROINFLAMMATION | 2009 |
|
RU2512288C2 |
BENZOTHIAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITION EXHIBITING PROPERTY TO BIND AMYLOID AND METHOD FOR DETECTING AMYLOID DEPOSITS IN MAMMAL | 2004 |
|
RU2440995C2 |
CHEMICAL COMPOUNDS FOR COATING NANOSTRUCTURES | 2018 |
|
RU2757904C2 |
Authors
Dates
2017-09-04—Published
2012-12-18—Filed